Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy? - Wikidata - wikimedia - TriplyDB

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

http://www.wikidata.org/entity/Q47221163

about

Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages Genomics of adult and pediatric solid tumors

P2860

Q57300016-AFA1F80F-540A-4C18-A716-B505B180DD59 Q58804574-708CBE19-82C7-416A-89AF-8353C7427AE2

P2860

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

http://www.wikidata.org/entity/Q47221163

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@en

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@nl

type

label

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@en

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@nl

prefLabel

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@en

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@nl

P1433

Q47221163-EA57C2A8-67E2-447D-BF9B-CBEDA5EB1837

P1476

Q47221163-7408B53F-01C2-47AE-A757-03B671881A3F

P2093

Q47221163-4885DC26-B844-4BF1-979F-CB862C0C0769

Q47221163-E965C61D-93A4-46E6-9306-EC93BB4C6A7E

P2860

Q47221163-00D40EF6-7A3B-472F-8703-5706415DB86C

Q47221163-0137BAC9-E9CE-447C-8F43-9DDD20F9F559

Q47221163-021EC616-0087-4C15-98A8-31CCCCAF1CDB

Q47221163-03178651-4A0D-4C71-9B35-AB12BEC66A49

Q47221163-0341F97E-499C-4A0B-A0A2-95837F404EC1

Q47221163-03CAA254-9107-45CA-BD69-92FF27B31394

Q47221163-0716B145-D2A0-4059-A5FD-F1B99E6B09F0

Q47221163-09282DD8-E20B-4445-BBF4-246826BC95F9

Q47221163-0B057433-88D4-4D0E-8EAB-5A6C70050CBD

Q47221163-0C129948-DF62-4BBB-A0E6-E8A8972E8610

P304

Q47221163-A512EA9C-44AB-4456-83AD-AF4EF9BC9E0C

P31

Q47221163-FC52F3BF-2BB1-425F-8D88-B5060FB3CC34

P356

Q47221163-80ED2806-98EE-408E-A8F2-7D3C64A146CC

P478

Q47221163-C4F83C16-8D6A-4674-AEBC-CB0CEA7B6A78

P577

Q47221163-5401CB93-0483-46E2-B567-ABB20F3CEA9D

P698

Q47221163-3B368056-A7DA-4549-A456-1555FB77F90D

P921

Q47221163-DCCF0F13-D6E9-48E9-A500-308DA904E87E

P932

Q47221163-208C7D0D-E2CA-4F5E-ABEC-3E11708647F9

P356

FIMMU.2017.01848

P1433

Frontiers in Immunology

P1476

Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

@en

P2093

Florian Kühnel

http://www.w3.org/2001/XMLSchema#string

Thomas C Wirth

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary dynamics of cancer in response to targeted combination therapy

Cancer genome landscapes

Immunotherapy: past, present and future

Hallmarks of Cancer: The Next Generation

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cell activation

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

P304

1848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01848

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312332

http://www.w3.org/2001/XMLSchema#string

P921

P932

5742119

http://www.w3.org/2001/XMLSchema#string